Press Releases April 30, 2026 04:05 PM

Strata Acquires Ohio Valley Perfusion Associates

Strata Critical Medical expands its clinical footprint with acquisition of Ohio Valley Perfusion Associates, enhancing cardiac perfusion services.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
SRTA

Strata Critical Medical, Inc. completed the acquisition of Ohio Valley Perfusion Associates, a regional provider of perfusion services in Ohio and Pennsylvania. The acquisition strengthens Strata's clinical platform in these regions, enabling expansion of services like ECMO support and organ recovery. The purchase aligns with Strata's M&A strategy, reflecting attractive financial terms and fits well with its focus on growing transplant-related businesses and fragmented cardiac perfusion markets.

Strata Acquires Ohio Valley Perfusion Associates
SRTA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Acquisition expands Strata's clinical services in Eastern Ohio and Western Pennsylvania, enhancing cardiac surgery support capabilities.
  • The deal was completed at a favorable valuation, consistent with Strata's strategic framework and targets mid-single digit EBITDA multiples.
  • Cardiac perfusion market is fragmented with attractive recurring revenue streams and multi-year contracts, providing growth opportunities via organic expansion and acquisitions.

NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced that it has completed the acquisition of Ohio Valley Perfusion Associates ("OVPA"), a regional provider of perfusion services to cardiac surgery programs in Ohio and Pennsylvania.

“Expanding our presence in Eastern Ohio and Western Pennsylvania is an important step in strengthening Strata’s regional clinical platform,” said Louis Verdetto, CEO of Strata’s Clinical Services Division. “These programs align well with our existing operations and allow us to further leverage our team of highly trained perfusionists to support cardiac surgery programs while continuing to expand advanced services such as ECMO support and organ recovery.”

“This transaction represents an exciting opportunity for our team and the programs we support,” said Richard Marcotte, Founder of Ohio Valley Perfusion Associates. “Through our partnership with Strata, we will gain access to additional clinical resources, technology, and infrastructure that will enable us to expand our services and better support our hospital partners across the region.”

“This bolt on acquisition is a perfect fit with our existing clinical operations and M&A strategy while coming at an attractive mid-single digit multiple of EBITDA, consistent with our target valuation framework,” said Mat Schneider, CFO of Strata’s Clinical Services Division. “The cardiac perfusion business has several highly attractive attributes including recurring revenue, multi-year contracts, high customer retention and the industry remains fragmented. In addition to our focus on growing our transplant related businesses, we view cardiac perfusion as an attractive platform to grow both organically and through acquisitions over the coming years.”

Ohio Valley Perfusion Associates serves customers in Ohio and Pennsylvania providing perfusion and related services including ECMO and autotransfusion with a team of eight highly trained and certified clinicians. The purchase price is approximately $1 million.

About Strata Critical Medical, Inc.

Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.

Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.

For more information, visit https://stratacritical.com/.

Contacts

Mathew Schneider
investors@srta.com


Risks

  • Integration risk of Ohio Valley Perfusion Associates into Strata's existing operations and potential execution challenges.
  • Market competition and reimbursement pressures in the healthcare and perfusion services sectors could impact profitability.
  • Dependence on continued multi-year contracts and retention of highly trained clinicians to sustain growth and service quality.

More from Press Releases

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026